Microenvironmental Interactions in Chronic Lymphocytic Leukemia: The Master Role of CD49d

被引:37
作者
Dal Bo, Michele [1 ]
Tissino, Erika [1 ]
Benedetti, Dania [1 ]
Caldana, Chiara [1 ]
Bomben, Riccardo [1 ]
Del Poeta, Giovanni [2 ,3 ]
Gaidano, Gianluca [4 ]
Rossi, Francesca Maria [1 ]
Zucchetto, Antonella [1 ]
Gattei, Valter [1 ]
机构
[1] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, I-33081 Aviano, PN, Italy
[2] S Eugenio Hosp, Div Hematol, Rome, Italy
[3] Univ Roma Tor Vergata, Rome, Italy
[4] Amedeo Avogadro Univ Eastern Piedmont, Dept Clin & Expt Med, Div Hematol, Novara, Italy
关键词
B-CELL RECEPTOR; TYROSINE KINASE INHIBITOR; IN-SITU HYBRIDIZATION; MARROW STROMAL CELLS; BONE-MARROW; ALPHA-4-BETA-1; INTEGRIN; ANTIGEN-RECEPTOR; LYMPH-NODES; SPONTANEOUS APOPTOSIS; DEPENDENT REGULATION;
D O I
10.1053/j.seminhematol.2014.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic lymphocytic leukemia (CLL) is a clinically heterogeneous disease characterized by the accumulation/expansion of a clonal population of neoplastic cells with the morphologic appearance of small mature B lymphocytes in blood, bone marrow, and lymphoid organs. A combination of genetic lesions is primarily responsible for the first step(s) of neoplastic transformation, along with microenvironmental signals, which concurrently operate by enhancing proliferation and/or inhibiting apoptosis. In this context, CD49d is known to play a pivotal role in mediating both cell-cell and cell-matrix interactions in CLL-involved tissues, eventually delivering pro-survival signals and protecting CLL cells from drug-induced damages. In the present review, we address, in detail, CD49d activities in the CLL microenvironment, CD49d functional and physical interactions with other microenvironmental receptors (including CD38 and B-cell receptor), and the relationship of CD49d expression with specific cytogenetic features in CLL. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:168 / 176
页数:9
相关论文
共 96 条
[21]   IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells [J].
Coscia, M. ;
Pantaleoni, F. ;
Riganti, C. ;
Vitale, C. ;
Rigoni, M. ;
Peola, S. ;
Castella, B. ;
Foglietta, M. ;
Griggio, V. ;
Drandi, D. ;
Ladetto, M. ;
Bosia, A. ;
Boccadoro, M. ;
Massaia, M. .
LEUKEMIA, 2011, 25 (05) :828-837
[22]   Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy [J].
Dal Bo, Michele ;
Bomben, Riccardo ;
Zucchetto, Antonella ;
Del Poeta, Giovanni ;
Gaidano, Gianluca ;
Deaglio, Silvia ;
Efremov, Dimitar G. ;
Gattei, Valter .
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (23) :3323-3334
[23]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847
[24]   EMILIN1/α9β1 Integrin Interaction Is Crucial in Lymphatic Valve Formation and Maintenance [J].
Danussi, Carla ;
Belluz, Lisa Del Bel ;
Pivetta, Eliana ;
Modica, Teresa Maria Elisa ;
Muro, Andres ;
Wassermann, Bruna ;
Doliana, Roberto ;
Sabatelli, Patrizia ;
Colombatti, Alfonso ;
Spessotto, Paola .
MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (22) :4381-4394
[25]   EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation [J].
Danussi, Carla ;
Petrucco, Alessandra ;
Wassermann, Bruna ;
Pivetta, Eliana ;
Modica, Teresa Maria Elisa ;
Belluz, Lisa Del Bel ;
Colombatti, Alfonso ;
Spessotto, Paola .
JOURNAL OF CELL BIOLOGY, 2011, 195 (01) :131-145
[26]   Fibronectin interaction with α4β1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia:: correlation with Bcl-2 and Bax [J].
de la Fuente, MT ;
Casanova, B ;
Garcia-Gila, M ;
Silva, A ;
Garcia-Pardo, A .
LEUKEMIA, 1999, 13 (02) :266-274
[27]   Involvement of p53 in α4β1 integrin-mediated resistance of B-CLL cells to fludarabine [J].
de la Fuente, MT ;
Casanova, B ;
Cantero, E ;
del Cerro, MH ;
Garcia-Marco, J ;
Silva, A ;
Garcia-Pardo, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (03) :708-712
[28]  
de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495
[29]   The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia [J].
de Rooij, Martin F. M. ;
Kuil, Annemieke ;
Geest, Christian R. ;
Eldering, Eric ;
Chang, Betty Y. ;
Buggy, Joseph J. ;
Pals, Steven T. ;
Spaargaren, Marcel .
BLOOD, 2012, 119 (11) :2590-2594
[30]   CD38/CD19: a lipid raft-dependent signaling complex in human B cells [J].
Deaglio, Silvia ;
Vaisitti, Tiziana ;
Billington, Richard ;
Bergui, Luciana ;
Omede, Paola ;
Genazzani, Armando A. ;
Malavasi, Fabio .
BLOOD, 2007, 109 (12) :5390-5398